Enumeral Biomedical Holdings, Inc. Derivative, Gain on Derivative
Enumeral Biomedical Holdings, Inc. reported Derivative, Gain on Derivative of $1.61 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-28.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainOnDerivative · last filed 2017-03-28
- Enumeral Biomedical Holdings, Inc. derivative, gain on derivative for the quarter ending 2014-12-31 was $183.66K.
- Enumeral Biomedical Holdings, Inc. derivative, gain on derivative for the quarter ending 2014-09-30 was $621.00.
- Enumeral Biomedical Holdings, Inc. derivative, gain on derivative for fiscal 2016 was $1.61M, a 88.50% decline from fiscal 2015.
- Enumeral Biomedical Holdings, Inc. derivative, gain on derivative for fiscal 2015 was $13.98M, a 7479.76% increase from fiscal 2014.
- Enumeral Biomedical Holdings, Inc. derivative, gain on derivative for fiscal 2014 was $184.45K.
| Period end | Derivative, Gain on Derivative 3 month | Derivative, Gain on Derivative 6 month | Derivative, Gain on Derivative 9 month | Derivative, Gain on Derivative 12 month |
|---|---|---|---|---|
| 2016-12-31 | $1.61M 10-K · filed 2017-03-28 | |||
| 2015-12-31 | $13.98M 10-K · filed 2017-03-28 | |||
| 2014-12-31 | $183.66K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $184.28K derived: sum of 2 quarters · filed 2015-03-19 | $184.45K 10-K · filed 2015-03-19 | |
| 2014-09-30 | $621.00 10-Q · filed 2014-11-14 | $789.00 10-Q · filed 2014-11-14 |